Literature DB >> 35175820

From cohorts to molecules: Adverse impacts of endocrine disrupting mixtures.

Carl-Gustaf Bornehag1,2, Barbara Demeneix3, Jean-Baptiste Fini3, Chris Gennings2, Joëlle Rüegg4,5, Joachim Sturve6, Giuseppe Testa7,8,9, Nicolò Caporale7,8,9, Michelle Leemans3, Lina Birgersson6, Pierre-Luc Germain7, Cristina Cheroni7,8,9, Gábor Borbély4, Elin Engdahl4,5, Christian Lindh10, Raul Bardini Bressan11, Francesca Cavallo7, Nadav Even Chorev7, Giuseppe Alessandro D'Agostino7, Steven M Pollard11, Marco Tullio Rigoli7,8, Erika Tenderini7, Alejandro Lopez Tobon7, Sebastiano Trattaro7,8, Flavia Troglio7, Matteo Zanella7, Åke Bergman4,12,13, Pauliina Damdimopoulou4,14, Maria Jönsson5, Wieland Kiess15, Efthymia Kitraki16, Hannu Kiviranta17, Eewa Nånberg18, Mattias Öberg4,19, Panu Rantakokko17, Christina Rudén12, Olle Söder20.   

Abstract

Convergent evidence associates exposure to endocrine disrupting chemicals (EDCs) with major human diseases, even at regulation-compliant concentrations. This might be because humans are exposed to EDC mixtures, whereas chemical regulation is based on a risk assessment of individual compounds. Here, we developed a mixture-centered risk assessment strategy that integrates epidemiological and experimental evidence. We identified that exposure to an EDC mixture in early pregnancy is associated with language delay in offspring. At human-relevant concentrations, this mixture disrupted hormone-regulated and disease-relevant regulatory networks in human brain organoids and in the model organisms Xenopus leavis and Danio rerio, as well as behavioral responses. Reinterrogating epidemiological data, we found that up to 54% of the children had prenatal exposures above experimentally derived levels of concern, reaching, for the upper decile compared with the lowest decile of exposure, a 3.3 times higher risk of language delay.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35175820     DOI: 10.1126/science.abe8244

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  10 in total

Review 1.  The Emerging Roles of Long Non-Coding RNAs in Intellectual Disability and Related Neurodevelopmental Disorders.

Authors:  Carla Liaci; Lucia Prandi; Lisa Pavinato; Alfredo Brusco; Mara Maldotti; Ivan Molineris; Salvatore Oliviero; Giorgio R Merlo
Journal:  Int J Mol Sci       Date:  2022-05-30       Impact factor: 6.208

2.  The EU chemicals strategy for sustainability: an opportunity to develop new approaches for hazard and risk assessment.

Authors:  Stefan Scholz; Werner Brack; Beate I Escher; Jörg Hackermüller; Matthias Liess; Martin von Bergen; Lukas Y Wick; Ana C Zenclussen; Rolf Altenburger
Journal:  Arch Toxicol       Date:  2022-08       Impact factor: 6.168

3.  Synergistic Activity of Ketoconazole and Miconazole with Prochloraz in Inducing Oxidative Stress, GSH Depletion, Mitochondrial Dysfunction, and Apoptosis in Mouse Sertoli TM4 Cells.

Authors:  Sabrina Petricca; Giuseppe Celenza; Carla Luzi; Benedetta Cinque; Anna Rita Lizzi; Nicola Franceschini; Claudio Festuccia; Roberto Iorio
Journal:  Int J Mol Sci       Date:  2022-05-12       Impact factor: 6.208

Review 4.  The Exposome and Toxicology: A Win-Win Collaboration.

Authors:  Robert Barouki; Karine Audouze; Christel Becker; Ludek Blaha; Xavier Coumoul; Spyros Karakitsios; Jana Klanova; Gary W Miller; Elliott J Price; Denis Sarigiannis
Journal:  Toxicol Sci       Date:  2022-02-28       Impact factor: 4.109

5.  A Mixture of Endocrine Disrupting Chemicals Associated with Lower Birth Weight in Children Induces Adipogenesis and DNA Methylation Changes in Human Mesenchymal Stem Cells.

Authors:  Polina Lizunkova; Elin Engdahl; Gábor Borbély; Chris Gennings; Christian Lindh; Carl-Gustaf Bornehag; Joëlle Rüegg
Journal:  Int J Mol Sci       Date:  2022-02-19       Impact factor: 5.923

6.  Endocrine disrupting chemicals interfere with decidualization of human primary endometrial stromal cells in vitro.

Authors:  Darja Lavogina; Nadja Visser; Külli Samuel; Eva Davey; Richelle D Björvang; Jasmin Hassan; Jani Koponen; Panu Rantakokko; Hannu Kiviranta; Ago Rinken; Matts Olovsson; Andres Salumets; Pauliina Damdimopoulou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-19       Impact factor: 6.055

7.  Comparative Evaluation of the Effects of Legacy and New Generation Perfluoralkyl Substances (PFAS) on Thyroid Cells In Vitro.

Authors:  Luca De Toni; Andrea Di Nisio; Maria Santa Rocca; Federica Pedrucci; Andrea Garolla; Stefano Dall'Acqua; Diego Guidolin; Alberto Ferlin; Carlo Foresta
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

8.  Organophosphate esters cause thyroid dysfunction via multiple signaling pathways in zebrafish brain.

Authors:  Zhenfei Yan; Chenglian Feng; Xiaowei Jin; Fangkun Wang; Cong Liu; Na Li; Yu Qiao; Yingchen Bai; Fengchang Wu; John P Giesy
Journal:  Environ Sci Ecotechnol       Date:  2022-06-06

Review 9.  Nanotechnologies in Obstetrics and Cancer during Pregnancy: A Narrative Review.

Authors:  Serena Bertozzi; Bruna Corradetti; Luca Seriau; José Andrés Diaz Ñañez; Carla Cedolini; Arrigo Fruscalzo; Daniela Cesselli; Angelo Cagnacci; Ambrogio P Londero
Journal:  J Pers Med       Date:  2022-08-17

Review 10.  Human cerebral organoids - a new tool for clinical neurology research.

Authors:  Oliver L Eichmüller; Juergen A Knoblich
Journal:  Nat Rev Neurol       Date:  2022-10-17       Impact factor: 44.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.